Song Zhiwang, Shao Chuan, Feng Chan, Lu Yonglin, Gao Yong, Dong Chunyan
Department of Oncology, Shanghai East Hospital, Tongji University, Shanghai, People's Republic of China.
Department of Neurosurgery, The Second Clinical Medical College of North Sichuan Medical College, Nanchong, Sichuan, People's Republic of China.
Ther Clin Risk Manag. 2016 May 12;12:763-9. doi: 10.2147/TCRM.S104339. eCollection 2016.
Several case-control studies investigating the relationship between genetic polymorphisms of glutathione S-transferase (GST) M1, GSTT1, and GSTP1 (rs1695) and the risk of breast cancer have reported contradictory results. We therefore performed a meta-analysis to clarify this issue.
An updated meta-analysis using PubMed and Web of Knowledge databases for the eligible case-control studies was performed. Random- or fixed-effects model was used.
A total of 10,067 cancer cases and 12,276 controls in 41 independent case-control studies from 19 articles were included in this meta-analysis. Significant increase in risk of breast cancer for Asians was found in GSTM1-null genotype (P=0.012, odds ratio [OR] =1.17, 95% confidence interval [CI] =1.04-1.32) and GSTT1-null genotype (P=0.039, OR =1.19, 95% CI =1.01-1.41). In addition, our results showed that the GSTP1 (rs1695) polymorphisms can significantly increase the risk among Caucasians (P=0.042, OR =1.16, 95% CI =1.01-1.34). Sensitivity analysis and publication bias further confirmed the dependability of the results in this meta-analysis.
Our results demonstrate that both GSTM1- and GSTT1-null polymorphisms are associated with an increased risk of breast cancer in Asians and that GSTP1 Val105Ile (rs1695) polymorphism is associated with an increased breast cancer risk in Caucasians.
多项病例对照研究探讨了谷胱甘肽S-转移酶(GST)M1、GSTT1和GSTP1(rs1695)的基因多态性与乳腺癌风险之间的关系,但结果相互矛盾。因此,我们进行了一项荟萃分析以阐明这一问题。
利用PubMed和Web of Knowledge数据库对符合条件的病例对照研究进行更新的荟萃分析。采用随机或固定效应模型。
本荟萃分析纳入了19篇文章中41项独立病例对照研究的总共10,067例癌症病例和12,276例对照。在亚洲人中,发现GSTM1缺失基因型(P = 0.012,比值比[OR] = 1.17,95%置信区间[CI] = 1.04 - 1.32)和GSTT1缺失基因型(P = 0.039,OR = 1.19,95% CI = 1.01 - 1.41)会显著增加患乳腺癌的风险。此外,我们的结果表明,GSTP1(rs1695)多态性可显著增加白种人的患病风险(P = 0.042,OR = 1.16,95% CI = 1.01 - 1.34)。敏感性分析和发表偏倚进一步证实了本荟萃分析结果的可靠性。
我们的结果表明,GSTM1和GSTT1缺失多态性均与亚洲人患乳腺癌风险增加相关,而GSTP1 Val105Ile(rs1695)多态性与白种人患乳腺癌风险增加相关。